Why Inovio Pharmaceuticals Inc (INO) Stock Could See Much Higher Prices Ahead

Inovio Pharmaceuticals Inc (NASDAQ: INO) is -84.22% lower on its value in year-to-date trading and has touched a low of $1.30 and a high of $12.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INO stock was last observed hovering at around $1.33 in the last trading session, with the day’s loss setting it 0.0%.

Currently trading at $1.33, the stock is -33.81% and -32.85% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.36 million and changing 0.00% at the moment leaves the stock -54.95% off its SMA200. INO registered -27.32% loss for a year compared to 6-month gain of -27.32%. The firm has a 50-day simple moving average (SMA 50) of $1.9806 and a 200-day simple moving average (SMA200) of $2.95265.

The stock witnessed a -38.71% loss in the last 1 month and extending the period to 3 months gives it a -16.35%, and is -36.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.53% over the week and 8.17% over the month.

Inovio Pharmaceuticals Inc (INO) has around 134 employees, a market worth around $48.78M and $0.28M in sales. Profit margin for the company is -34079.58%. Distance from 52-week low is 2.31% and -89.21% from its 52-week high. The company has generated returns on investments over the last 12 months (-160.94%).

The EPS is expected to grow by 47.65% this year.

Inovio Pharmaceuticals Inc (INO) Top Institutional Holders

146.0 institutions hold shares in Inovio Pharmaceuticals Inc (INO), with institutional investors hold 37.56% of the company’s shares. The shares outstanding are 36.67M, and float is at 36.38M with Short Float at 17.76%. Institutions hold 37.28% of the Float.

The top institutional shareholder in the company is DEEP TRACK CAPITAL, LP with over 2.07 million shares valued at $16.7 million. The investor’s holdings represent 7.5988% of the INO Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 1.71 million shares valued at $13.79 million to account for 6.2741 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 1.58 million shares representing 5.8151% and valued at over $12.78 million, while GEODE CAPITAL MANAGEMENT, LLC holds 2.1428 of the shares totaling 0.58 million with a market value of $4.71 million.

Inovio Pharmaceuticals Inc (INO) Insider Activity

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.